Levodopa and 3-O-Methyldopa Plasma Levels in Parkinsonian Patients with Stable and Fluctuating Motor Response
- 1 February 1989
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 12 (1) , 46-54
- https://doi.org/10.1097/00002826-198902000-00006
Abstract
Many parkinsonian patients with motor fluctuations in response to levodopa show a good response to initial morning doses but fail to respond in the afternoon and evening. We have studied levodopa and 3-O-methyldopa (3-OM-dopa) plasma profiles in 21 patients with fluctuations and eight patients with stable motor function throughout the day. Levodopa plasma peaks and valleys were similar for both groups of patients. No significant difference for levodopa absorption index [defined as levodopa plasma levels after each dose divided by the quantity (mg) of ingested levodopa] was found between the first and the second levodopa-carbidopa dose in either group of patients. Even in patients who failed to improve after the second levodopa-carbidopa tablet (p.o.) on the day of the study, no significant variation in levodopa absorption index was observed. 3-OM-dopa values depended mainly upon levodopa consumption and were not different for patients with fluctuating or stable motor response. These findings provide further evidence of the prime role of central pharmacokinetic and pharmacodynamic factors in the pathogenesis of motor fluctuations in Parkinson''s disease.This publication has 12 references indexed in Scilit:
- 3‐O‐Methyldopa and the response to levodopa in Parkinson's diseaseAnnals of Neurology, 1987
- Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patientsNeurology, 1987
- 3–0‐methyldopa and motor fluctuations in Parkinson's diseaseNeurology, 1987
- Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Dopamine D2 receptor density remains constant in treated Parkinson's diseaseAnnals of Neurology, 1986
- Control of on/off phenomenon by continuous intravenous infusion of levodopaNeurology, 1984
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- Plasma DOPA and growth hormone in parkinsonismNeurology, 1979
- The Clinical Picture and Plasma Levodopa Metabolite Profile of Parkinsonian NonrespondersArchives of Neurology, 1977
- "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPYThe Lancet, 1976